Floatz logo

Evolocumab

Acute Stroke

The Affiliated Hospital of Xuzhou Medical Universitymonoclonal_antibodyPhase 4 / ApprovedActive
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Acute Stroke cohort.

Asset / SponsorPhaseRating
Humulin R
First Affiliated Hospital of Wannan Medical College
Phase 4BBB
Danhong
China Academy of Chinese Medical Sciences
Phase 4BB
DEXAMETHASONE
Shaheed Zulfiqar Ali Bhutto Medical University
Phase 4BB
Elavolocumab
The Affiliated Hospital of Xuzhou Medical University
Phase 4BB
Ivolumab
The Affiliated Hospital of Xuzhou Medical University
Phase 4BB

View all 29 →

Same molecule, other indications

Evolocumab is also rated in:

cardiovascular disorderDormant
B
Indicative ·
63 / 100
View asset →
myocardial infarctionDormant
B
Indicative ·
63 / 100
View asset →
Subjects With Hyperlipidemia, Dyslipidemia and HIV InfectionDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →